ReSTORE CD101.IV.3.05 (#1254)
Laufzeit: 01.01.2021 - 31.12.2021
imported
Kurzfassung
A Phase 3, Multicenter, Randomized, Double-blind Study of the Efficacy and Safety of Rezafungin for Injection versus Intravenous Caspofungin Followed by Optional Oral Fluconazole Step-down in the Treatment of Subjects with Candidemia and/or Invasive Candidiasis (The ReSTORE Study)